Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 26 min ago
Peer-reviewedLicence not statedJournal of Hepatology

Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma

  • Isabelle Ollivier-Hourmand
  • Manon Allaire
  • Jean Paul Cervoni
  • Delphine Weil
  • Violaine Ozenne
  • Pierre Emmanuel Rautou
  • Charlotte Bouzbib
  • Sabrina Sidali
  • Frédéric Oberti
  • Maeva Guillaume
  • Paul Castellani
  • Paul Calame
2 more authors
  • Sandrine Barge
  • Christophe Bureau
Open at sourcePDFDOICite

Related

  1. Efficacy and safety of sintilimab plus bevacizumab with or without transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score-matched retrospective cohort study
    Zizhuo Wang, Bailu Wu, Chunshu Wu +7
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  2. Multimodal investigation of the association between bevacizumab and pulmonary arterial hypertension
    Simon Valentin, Alex Hlavaty, Coline Brossat +10
    ERJ open researchPeer-reviewedCC BY-NCFull textGeneral biologyEurope PMCHAL
  3. Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report
    Qin Xu, Xiaofen Li, Rui Zhu +4
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  4. Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach
    Abbas Mourad, Sylvie Deuffic-Burban, Nathalie Ganne-Carrié +10
    HepatologyPeer-reviewedLicence not statedFull text54 citedGeneral biologyHAL
  5. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
    Roser Pinyol, Sara Torrecilla, Huan Wang +32
    Journal of HepatologyPeer-reviewedLicence not statedFull text252 citedGeneral biologyHAL

Cite

BibTeXRIS
BibTeX
@article{ollivierhourmand2026management,
  title = {{Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma}},
  author = {Isabelle Ollivier-Hourmand and Manon Allaire and Jean Paul Cervoni and Delphine Weil and Violaine Ozenne and Pierre Emmanuel Rautou and Charlotte Bouzbib and Sabrina Sidali and Frédéric Oberti and Maeva Guillaume and Paul Castellani and Paul Calame and Sandrine Barge and Christophe Bureau},
  journal = {Journal of Hepatology},
  year = {2026},
  month = sep,
  doi = {10.1016/j.jhep.2022.02.004},
  url = {https://hal.science/hal-05743667v1},
}
RIS
TY  - JOUR
TI  - Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma
AU  - Isabelle Ollivier-Hourmand
AU  - Manon Allaire
AU  - Jean Paul Cervoni
AU  - Delphine Weil
AU  - Violaine Ozenne
AU  - Pierre Emmanuel Rautou
AU  - Charlotte Bouzbib
AU  - Sabrina Sidali
AU  - Frédéric Oberti
AU  - Maeva Guillaume
AU  - Paul Castellani
AU  - Paul Calame
AU  - Sandrine Barge
AU  - Christophe Bureau
PY  - 2026
DA  - 2026/09/09
JO  - Journal of Hepatology
DO  - 10.1016/j.jhep.2022.02.004
UR  - https://hal.science/hal-05743667v1
SN  - 0168-8278
SN  - 1600-0641
ER  -